AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. Currently, AmeriCann has a multi-market portfolio of over 1,000,000 square feet of sustainable cannabis production infrastructure in various stages of development which consists of 125,000 square feet of approved cultivation and processing infrastructure on the 5 acres located at 5280 Monaco St. in Denver, and site approval for 977,000 square feet of cultivation, processing and administration infrastructure at the Massachusetts Medical Cannabis Center ("MMCC").
AmeriCann's team includes board members, consultants, engineers and architects who specialize in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development.
To support local businesses that seek to serve cannabis patients in their communities AmeriCann initiated the AmeriCann Preferred Partner Program. The initial step in becoming a Preferred Partner involves an application on their website. Based on the initial inquiry, AmeriCann determines if the location, market,
type of project and economics support additional due diligence. Currently, they have
AMERICANN, INC.
BOSTON, MA & DENVER, CO
Issued & Outstanding: 16.63M
Market Cap: 10.39M
52 Week Range: $0.30 - $0.96